美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Beta Bionics, Inc.

14.84

+0.41002.84%

盘后：14.840.00000.00%18:45 EDT

成交量：35.55万

成交额：525.16万

市值：6.43亿

市盈率：-2.62

高：15.10

开：14.33

低：14.00

收：14.43

数据加载中...

总览公司新闻公告

Beta Bionics Inc 预计每股亏损 45 美分 - 财报前瞻

BUZZ--美国股票走势-NIP Group、凯悦酒店、BioXcel Therapeutics

BUZZ-CMS 提出招标计划变更后，糖尿病设备制造商业绩下滑

Beta Bionics(BBNX.US)获Truist Securities首次覆盖，给予买入评级, 目标价26.00美元。

Beta Bionics获Wolfe Research首次覆盖，给予优于大市评级, 目标价20.00美元。

Beta Bionics Inc 预计每股亏损 48 美分 - 财报前瞻

Beta Bionics, Inc.2024财年实现净利润-54.76百万美元，同比减少190.50%

嗡嗡声--美国股票走势-Maze Therapeutics、UFP Technologies、Itron

嗡嗡声--美国股票走势-礼来、Krispy Kreme、贝宝

BUZZ-美银美林开始覆盖胰岛素设备制造商 Beta Bionics，给予 "买入 "评级

嗡嗡声--美国股票走势-星巴克、百时美施贵宝、家得宝

BUZZ-华尔街看好上市后的胰岛素设备制造商 Beta Bionics

Beta Bionics(BBNX.US)获Stifel首次覆盖，给予买入评级, 目标价25.00美元。

Beta Bionics(BBNX.US)获Lake Street首次覆盖，给予买入评级, 目标价30.00美元。

Beta Bionics(BBNX.US)获Piper Sandler首次覆盖，给予增持评级, 目标价26.00美元。

Beta Bionics(BBNX.US)获Leerink Partners首次覆盖，给予优于大市评级, 目标价28.00美元。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BBNX/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBNX\",,,,,undefined,":{"symbol":"BBNX","market":"US","secType":"STK","nameCN":"Beta Bionics, Inc.","latestPrice":14.84,"timestamp":1753473600000,"preClose":14.43,"halted":0,"volume":355455,"hourTrading":{"tag":"盘后","latestPrice":14.84,"preClose":14.84,"latestTime":"18:45 EDT","volume":2349,"amount":34889.41,"timestamp":1753483515271},"delay":0,"floatShares":26238813,"shares":43356281,"eps":-5.659705,"marketStatus":"休市中","change":0.41,"latestTime":"07-25 16:00:00 EDT","open":14.33,"high":15.1,"low":14,"amount":5251603.78287,"amplitude":0.07623,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.659705,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1753689600000},"marketStatusCode":7,"adr":0,"listingDate":1738213200000,"exchange":"NASDAQ","adjPreClose":14.43,"preHourTrading":{"tag":"盘前","latestPrice":14.71,"preClose":14.43,"latestTime":"08:00 EDT","volume":1,"amount":14.71,"timestamp":1753444802368},"postHourTrading":{"tag":"盘后","latestPrice":14.84,"preClose":14.84,"latestTime":"18:45 EDT","volume":2349,"amount":34889.41,"timestamp":1753483515271},"volumeRatio":1.1057849047464579},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBNX\",,,,,undefined,":{"symbol":"BBNX","floatShares":26238813,"roa":"-21.78%","roe":"-81.35%","lyrEps":-8.602584,"volumeRatio":1.1057849047464579,"shares":43356281,"dividePrice":0,"high":15.1,"amplitude":0.07623,"preClose":14.43,"low":14,"week52Low":8.89,"pbRate":"2.05","psRate":"9.21","week52High":24.5,"institutionHeld":0,"latestPrice":14.84,"eps":-5.659705,"divideRate":0,"volume":355455,"delay":0,"ttmEps":-5.659705,"open":14.33,"prevYearClose":17,"prevWeekClose":13.59,"prevMonthClose":14.56,"prevQuarterClose":14.56,"fiveDayClose":13.59,"twentyDayClose":14.99,"sixtyDayClose":10.99,"earningDate":1753718400000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBNX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2554677794","title":"Beta Bionics Inc  预计每股亏损 45 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2554677794","media":"路透中文","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554677794?lang=zh_cn&edition=fundamental","pubTime":"2025-07-26 04:07","pubTimestamp":1753474029,"startTime":"0","endTime":"0","summary":"Beta Bionics Inc  预计每股亏损 45 美分 - 财报前瞻Beta Bionics Inc BBNX.OQ BBNX.O 预计将于7月29日公布截至2025年6月30日的财报。根据LSEG的数据，9位分析师的平均预期是，这家总部位于加利福尼亚州欧文市的公司预计将实现1968.4万美元的营收。LSEG 的分析师平均预计 Beta Bionics 公司每股亏损 45 美分。华尔街对 Beta Bionics 公司 12 个月目标价的中位数为 26.00 美元，比上次收盘价 14.43 美元高出约 44.5%。7月25日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nL4T3TM1J3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX"],"gpt_icon":0},{"id":"2548900430","title":"BUZZ--美国股票走势-NIP Group、凯悦酒店、BioXcel Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2548900430","media":"路透中文","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548900430?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 21:13","pubTimestamp":1751375632,"startTime":"0","endTime":"0","summary":"nL4N3SY0TC ** Trade Desk Inc < TTD.O  >:BUZZ - 在花旗银行上调 PT 后上涨 nL4N3SY0UP ** Zscaler Inc < ZS.O  >:BUZZ - 在出售 15 亿美元可转债后下跌 nL6N3SY0HS ** Ormat Technologies Inc < ORA.N  >:BUZZ - 由于无碳电力需求上升，Jefferies 上调 Ormat Technologies 的 PT nL4N3SY0UG ** Nektar Therapeutics Inc < NKTR.O  >:BUZZ - 1亿美元股票出售后走低 nL6N3SY0K8 ** Nike Inc < NKE.N  >:BUZZ - Argus Research将耐克公司的评级提升至 \"买入\"，认为其市场主导地位仍将持续。nL4N3RM0VN ** BioXcel Therapeutics Inc < BTAI.O  >:BUZZ - 因精神分裂症药物试验推荐结果良好而上涨。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nL4T3SY0ZV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AU","BTAI","BK4009","LU2112291526.USD","H","LU0648001328.SGD","AMC","BBNX","LVS","WYNN","CDE","LU2063271972.USD","BK4503","LU1066051811.HKD","ORA","TSYW.SI","BK4511","NIPG","IE00B894F039.SGD","ZS","LU2237443549.SGD","LU1674673691.USD","TTD","BK4527","SG","SYF","TNDM","SG9999004303.SGD","NEM","HL","BK4141","LU1691799644.USD","LU0612318385.USD","DXCM","DYN","LU0278409577.USD","ABT","CTAS","LU1720051108.HKD","IE0009355771.USD"],"gpt_icon":1},{"id":"2548064870","title":"BUZZ-CMS 提出招标计划变更后，糖尿病设备制造商业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2548064870","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548064870?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 20:02","pubTimestamp":1751371376,"startTime":"0","endTime":"0","summary":"BUZZ-CMS 提出招标计划变更后，糖尿病设备制造商业绩下滑7月1日 -  ** 糖尿病设备制造商 DexCom DXCM.O 和 Tandem Diabetes Care TNDM.O 的股价盘前分别下跌近 4 ** DXCM 下跌3.8%，报84美元，TNDM下跌3.9%，报17.92美元 ** 美国医疗保险与医疗补助服务中心周一晚些时候提议修改竞争性招标计划，旨在降低糖尿病 患者购买胰岛素泵、连续血糖监测仪 和其他设备的共付额。** 摩根大通称，这些变化将影响到生产 CGM 的雅培ABT.N和 DXCM，以及 胰岛素泵制造商 TNDM 和 Beta Bionics BBNX.O。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nL4S3SY0VS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","BK4585","LU1923622614.USD","SG9999004303.SGD","BK4534","TNDM","ABT","BK4588","IE0009355771.USD","LU1989763690.USD","LU2237957902.USD","SGXZ23171101.USD","BK4533","LU1691799644.USD","LU1721429741.USD","LU2237957811.SGD","LU2468319806.SGD","LU0266013472.USD","IE00BJT1NW94.SGD","BK4566","BK4548","IE00BFTCPJ56.SGD","LU1914381329.SGD","IE00BMPRXN33.USD","LU0170899867.USD","LU0354030438.USD","LU2089984988.USD","IE00B2B36J28.USD","LU1061106388.HKD","LU1989763427.SGD","LU2211815571.USD","SG9999002232.USD","BK4592","IE00BMPRXR70.SGD","DXCM","LU2125909593.SGD","IE00B4R5TH58.HKD","BK4082","LU1323610961.USD","BBNX","BK4568","LU0354030511.USD","LU0122379950.USD","LU0868494617.USD","SG9999002224.SGD","LU2433249047.HKD","LU2125909247.SGD","LU1057294990.SGD","LU2133065610.SGD","BK4581"],"gpt_icon":0},{"id":"2544046746","title":"Beta Bionics(BBNX.US)获Truist Securities首次覆盖，给予买入评级, 目标价26.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2544046746","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544046746?lang=zh_cn&edition=fundamental","pubTime":"2025-06-17 00:20","pubTimestamp":1750090806,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Truist Securities首次覆盖，给予买入评级, 目标价26.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/17002051100004.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"gpt_icon":0},{"id":"2539427938","title":"Beta Bionics获Wolfe Research首次覆盖，给予优于大市评级, 目标价20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2539427938","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539427938?lang=zh_cn&edition=fundamental","pubTime":"2025-05-30 23:44","pubTimestamp":1748619866,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Wolfe Research首次覆盖，给予优于大市评级, 目标价20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025053023493495086e76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025053023493495086e76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BBNX"],"gpt_icon":0},{"id":"2532803800","title":"Beta Bionics Inc  预计每股亏损 48 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2532803800","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532803800?lang=zh_cn&edition=fundamental","pubTime":"2025-05-03 06:48","pubTimestamp":1746226088,"startTime":"0","endTime":"0","summary":"Beta Bionics Inc  预计每股亏损 48 美分 - 财报前瞻Beta Bionics Inc BBNX.OQ BBNX.O 预计将于5月6日公布截至2025年3月31日的财报。LSEG 分析师对 Beta Bionics Inc 的平均预期是每股亏损 48 美分。华尔街对 Beta Bionics Inc 的 12 个月目标价中位数为 26.00 美元，高于其最新收盘价 11.14 美元。5月2日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250502:nL4S3RA2IC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX"],"gpt_icon":0},{"id":"2522385216","title":"Beta Bionics, Inc.2024财年实现净利润-54.76百万美元，同比减少190.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2522385216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522385216?lang=zh_cn&edition=fundamental","pubTime":"2025-03-26 23:00","pubTimestamp":1743001244,"startTime":"0","endTime":"0","summary":"3月26日，Beta Bionics, Inc.公布财报，公告显示公司2024财年净利润为-54.76百万美元，同比减少190.50%；其中营业收入为65.12百万美元，同比增加679.88%，每股基本收益为-8.60美元。从资产负债表来看，Beta Bionics, Inc.总负债73.63百万美元，其中短期债务1.53百万美元，资产负债比为0.03，流动比率为0.07。机构评级：截至2025年3月26日，当前有7家机构对Beta Bionics, Inc.目标价做出预测，其中目标均价为26.14美元，其中最低目标价为18.00美元，最高目标价为31.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250326230057a442bfc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250326230057a442bfc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BBNX"],"gpt_icon":0},{"id":"2514904306","title":"嗡嗡声--美国股票走势-Maze Therapeutics、UFP Technologies、Itron","url":"https://stock-news.laohu8.com/highlight/detail?id=2514904306","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514904306?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 03:44","pubTimestamp":1740512663,"startTime":"0","endTime":"0","summary":".N美国东部时间13:30，道琼斯工业平均指数.DJI上涨0.11%，报43,508.59点。标准普尔500指数.SPX下跌0.55%，报5950.58点；纳斯达克综合指数.IXIC下跌1.25%，报19045.13点。标准普尔 500 指数.PG.INX涨幅前三名是： ** Solventum Corp SOLV.N，上涨 10.4. ** Concord Medical Services Holdings Ltd CCM.N，上涨 15.7. 纳斯达克.PL.O百分比跌幅前三名： ** Transcode Therapeutics Inc RNAZ.OQ，下跌 42.5. ** Connexa Sports Technologies Inc YYAI.OQ，跌幅 40.9** Li Auto Inc LI.O，下跌 40.9%：。BUZZ - 美国银行开始对减肥药开发商Metsera进行评级，给予 \"买入 \"评级  nL3N3PG101. BUZZ - 美国银行开始对胰岛素设备制造商 Beta Bionics 进行 \"买入 \"评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3S3PG1YD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AHCO","MTSR","BBNX","ADIL","MAZE","AXGN","HRMY","KDP","NVDD","PODD","NVDS.UK","NVD2.UK","ONVO","IART","2NVD.UK","NVIW.SI","CAKE","DOMH","SNVD.UK","PTLO","RETO","UFPT","TNDM","BGC","TSYW.SI","HSIC","BBIO","EVER","DNUT","NVDU","STRK","NVDX","LVTX","CSCO","NVD3.UK","NVDY","ITRI","NTRA","GSHD"],"gpt_icon":1},{"id":"2514156097","title":"嗡嗡声--美国股票走势-礼来、Krispy Kreme、贝宝","url":"https://stock-news.laohu8.com/highlight/detail?id=2514156097","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514156097?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 22:30","pubTimestamp":1740493809,"startTime":"0","endTime":"0","summary":"nL3N3PG0XA ** JOYY Inc YY.O:BUZZ - 因百度收购该公司直播业务交易而上涨   nL3N3PG0YU ** Hims & Hers Health Inc HIMS.N:BUZZ - 因警告可能停止复方制剂Wegovy而下滑。nL3N3PG0XL ** Amer Sports Inc AS.N:BUZZ - 因年度预测大幅低于预期而下滑   nL3N3PG0ZA ** Unity Software U.N：BUZZ - 在6亿美元可转换交易定价后下滑  nL6N3PG0HC ** Civitas Resources Inc CIVI.N:BUZZ - 因第四季度利润不及预期而下跌    nL3N3PG10V ** Metsera Inc MTSR.O:BUZZ - 美国银行以 \"买入 \"评级开始覆盖减肥药开发商Metsera。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3T3PG1DP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEM","BKSY","ONVO","02020","PTLO","EVER","BBNX","KDP","MTSR","DOMH","CSCO","89888","AS","SNVD.UK","DNUT","YY","NIO.SI","NVDS","PYPL","SRE","IART","HRMY","ZM","LLY","CHGG","82020","CLF","AU","PLNT","CAKE","NTRA","NVIW.SI","CIVI","HD"],"gpt_icon":1},{"id":"2514952150","title":"BUZZ-美银美林开始覆盖胰岛素设备制造商 Beta Bionics，给予 \"买入 \"评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2514952150","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514952150?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 20:42","pubTimestamp":1740487367,"startTime":"0","endTime":"0","summary":"BUZZ-美银美林开始覆盖胰岛素设备制造商 Beta Bionics，给予 \"买入 \"评级2月25日 -  ** 博雅全球研究公司开始对胰岛素设备制造商 Beta Bionics BBNX.O 进行评级，给予 \"买入 \"评级，目标价为 25 美元，理由是该公司的 \"差异化闭环算法 \"简化了糖尿病患者的胰岛素剂量。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3S3PG149:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAC","BBNX"],"gpt_icon":0},{"id":"2514777872","title":"嗡嗡声--美国股票走势-星巴克、百时美施贵宝、家得宝","url":"https://stock-news.laohu8.com/highlight/detail?id=2514777872","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514777872?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 02:51","pubTimestamp":1740423080,"startTime":"0","endTime":"0","summary":".N 美东时间13:30，道琼斯工业平均指数.DJI上涨0.52%，报43,653.47点。标准普尔500指数.SPX上涨0.25%，报6028.09点；纳斯达克综合指数.IXIC下跌0.13%，报19497.88点。标准普尔500指数.PG.INX百分比涨幅前三名：** 耐克公司NKE.N，上涨5.0%** Live Nation娱乐公司LYV.N，上涨4.9%** 伯克希尔哈撒韦公司BRKb.N，上涨4.7. BUZZ--在Guggenheim将其评级提升至 \"买入 \"后上涨，因其销售有可能重新加速 nL3N3PF0QG. BUZZ - 因第四季度业绩 \"积极 \"而上涨 nL2N3PF0KY ** BioCryst Pharmaceuticals Inc BCRX.O:BUZZ - 因季度亏损幅度超过预期而下跌 nL3N3PF","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL3S3PF1C9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRDA","SEM","DPZ","NFE","BCRX","BRDG","RILY","NCLH","CTAS","SUI","SMMT","GFI","IVVD","SBUX","TWLO","LU0097036916.USD","IE00B3SWFQ91.USD","NEXT","LU2125154935.USD","SG9999014906.USD","BBNX","LU0354030511.USD","LU2552382215.SGD","RCL","LU0158827781.USD","MACW.SI","BBWI","LU2403377893.USD","YYAI","LU0080751232.USD","WING","FDP","BK4127","AMRX","BMY","PODD","AGIO","CCL","MDT","NMIH","ABR","SFD","SG9999002224.SGD","AXSM","BMRN"],"gpt_icon":1},{"id":"2513877875","title":"BUZZ-华尔街看好上市后的胰岛素设备制造商 Beta Bionics","url":"https://stock-news.laohu8.com/highlight/detail?id=2513877875","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513877875?lang=zh_cn&edition=fundamental","pubTime":"2025-02-24 23:35","pubTimestamp":1740411307,"startTime":"0","endTime":"0","summary":"BUZZ-华尔街看好上市后的胰岛素设备制造商 Beta Bionics2月24日 -  ** 随着首次公开募股研究静默期的结束，华尔街券商开始看好胰岛素设备制造商 Beta Bionics BBNX.O。** BofA Securities、Piper Sandler、Leerink Partners、Stifel 和 Lake Street 是首次公开募股的承销商。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL3T3PF15N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0052756011.USD","IE00B7SZLL34.SGD","LU0070302665.USD","LU0648001328.SGD","LU0787776722.HKD","LU1366192091.USD","BK4211","LU0640476718.USD","IE00BKVL7J92.USD","LU0053666078.USD","LU0170899867.USD","LU2129689514.USD","IE0002270589.USD","LU0208291251.USD","LU0130103400.USD","BK4559","SIVBQ","BAC","LU0130518102.USD","LU1267930227.SGD","LU0320765646.SGD","LU0980610538.SGD","IE00BLSP4452.SGD","LU1668664300.SGD","LU1880398554.USD","LU1201861165.SGD","LU1894683348.USD","BK4082","IE00BLSP4239.USD","LU0128525689.USD","LU0306806265.USD","BK4534","BK4589","LU1496350502.SGD","IE00BZ1G4Q59.USD","LU1718418525.SGD","LU1880398471.USD","LU1074936037.SGD","LU1201861249.SGD","LU1363072403.SGD","BK4588","LU0417517546.SGD","BBNX","IE00BBT3K403.USD","IE00B1BXHZ80.USD","LU0098860793.USD","LU0868494617.USD","LU0256863811.USD","LU0310800965.SGD","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2513777845","title":"Beta Bionics(BBNX.US)获Stifel首次覆盖，给予买入评级, 目标价25.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513777845","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513777845?lang=zh_cn&edition=fundamental","pubTime":"2025-02-24 23:21","pubTimestamp":1740410466,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Stifel首次覆盖，给予买入评级, 目标价25.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24232148353170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"gpt_icon":0},{"id":"2513722329","title":"Beta Bionics(BBNX.US)获Lake Street首次覆盖，给予买入评级, 目标价30.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722329","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513722329?lang=zh_cn&edition=fundamental","pubTime":"2025-02-24 22:22","pubTimestamp":1740406925,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Lake Street首次覆盖，给予买入评级, 目标价30.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24222248352806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"gpt_icon":0},{"id":"2513272995","title":"Beta Bionics(BBNX.US)获Piper Sandler首次覆盖，给予增持评级, 目标价26.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513272995","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513272995?lang=zh_cn&edition=fundamental","pubTime":"2025-02-24 21:21","pubTimestamp":1740403316,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Piper Sandler首次覆盖，给予增持评级, 目标价26.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24212148352460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"gpt_icon":0},{"id":"2513723151","title":"Beta Bionics(BBNX.US)获Leerink Partners首次覆盖，给予优于大市评级, 目标价28.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513723151","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513723151?lang=zh_cn&edition=fundamental","pubTime":"2025-02-24 20:20","pubTimestamp":1740399654,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Leerink Partners首次覆盖，给予优于大市评级, 目标价28.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24202048351403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBNX\",params:#limit:5,,,undefined,":[{"date":"2025-07-29","symbol":"BBNX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/06","expectedEps":-0.51,"defaultRemindTime":1753819200000,"name":null,"time":"盘后","dateTimestamp":1753761600000,"actualEps":null},{"market":"US","date":"2025-05-06","symbol":"BBNX","fiscalQuarterEnding":"2025/03","expectedEps":-0.51,"name":null,"time":"盘后","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":-0.52},{"market":"US","date":"2025-03-25","symbol":"BBNX","fiscalQuarterEnding":"2024/12","expectedEps":-0.42,"name":null,"time":"盘后","type":"earning","dateTimestamp":1742875200000,"reportTimeType":"post","actualEps":-1.82}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBNX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBNX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4444,"buy":0.3333,"hold":0.2222,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":9,"updateTime":1750132800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BBNX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BBNX","date":"2025-07-25","current":-8.816301,"percent":0.655738,"low":-18.401318,"twenty":-13.38389,"median":-9.506697,"eighty":-8.433029,"high":-3.90273,"avg":-10.948136,"sd":3.207738,"marketCap":625631134},"quantilePoints":[{"date":"2025-01-31","current":-18.262207,"twenty":-16.058067,"median":-12.751858,"eighty":-7.442381,"marketCap":1013479428},{"date":"2025-02-07","current":-18.125788,"twenty":-18.207639,"median":-17.701026,"eighty":-14.679009,"marketCap":1005908733},{"date":"2025-02-14","current":-16.797439,"twenty":-18.139689,"median":-17.569735,"eighty":-16.871579,"marketCap":932190666},{"date":"2025-02-21","current":-16.117818,"twenty":-18.053192,"median":-17.39983,"eighty":-16.806707,"marketCap":894474446},{"date":"2025-02-28","current":-15.376414,"twenty":-17.738096,"median":-16.901699,"eighty":-15.527784,"marketCap":853329479},{"date":"2025-03-07","current":-13.754592,"twenty":-17.625341,"median":-16.797439,"eighty":-14.919215,"marketCap":763324863},{"date":"2025-03-14","current":-10.843036,"twenty":-17.540388,"median":-16.156433,"eighty":-12.952405,"marketCap":601745147},{"date":"2025-03-21","current":-12.117325,"twenty":-17.418365,"median":-15.88613,"eighty":-12.19996,"marketCap":672463060},{"date":"2025-03-28","current":-10.030495,"twenty":-17.316422,"median":-15.090664,"eighty":-11.612243,"marketCap":549229802},{"date":"2025-04-04","current":-8.526317,"twenty":-16.978156,"median":-13.955389,"eighty":-11.224551,"marketCap":466867006},{"date":"2025-04-11","current":-8.462983,"twenty":-16.936452,"median":-12.789848,"eighty":-9.75816,"marketCap":463399099},{"date":"2025-04-17","current":-8.660901,"twenty":-16.843777,"median":-12.343221,"eighty":-9.270489,"marketCap":474236309},{"date":"2025-04-25","current":-8.755902,"twenty":-16.843777,"median":-12.117325,"eighty":-8.660901,"marketCap":479438170},{"date":"2025-05-02","current":-8.819236,"twenty":-16.797439,"median":-11.630778,"eighty":-8.660901,"marketCap":482906077},{"date":"2025-05-09","current":-9.109566,"twenty":-16.202771,"median":-11.468596,"eighty":-8.660901,"marketCap":646442149},{"date":"2025-05-16","current":-8.41306,"twenty":-16.195048,"median":-11.020664,"eighty":-8.526317,"marketCap":597015989},{"date":"2025-05-23","current":-9.476148,"twenty":-16.117818,"median":-10.030495,"eighty":-8.550067,"marketCap":672455918},{"date":"2025-05-30","current":-9.384503,"twenty":-15.951002,"median":-9.677769,"eighty":-8.619734,"marketCap":665952476},{"date":"2025-06-06","current":-11.944468,"twenty":-15.890764,"median":-10.161718,"eighty":-8.656151,"marketCap":847615293},{"date":"2025-06-13","current":-11.90781,"twenty":-15.527784,"median":-10.843036,"eighty":-8.663027,"marketCap":845013916},{"date":"2025-06-20","current":-10.863051,"twenty":-15.401128,"median":-10.973025,"eighty":-8.671464,"marketCap":770874676},{"date":"2025-06-27","current":-9.158444,"twenty":-15.033515,"median":-10.853044,"eighty":-8.690985,"marketCap":649910652},{"date":"2025-07-03","current":-8.260318,"twenty":-14.588672,"median":-10.413035,"eighty":-8.668829,"marketCap":586176919},{"date":"2025-07-11","current":-8.284756,"twenty":-14.14074,"median":-9.690076,"eighty":-8.535817,"marketCap":587911170},{"date":"2025-07-18","current":-8.043423,"twenty":-13.87507,"median":-9.628891,"eighty":-8.433029,"marketCap":570785439},{"date":"2025-07-25","current":-8.816301,"twenty":-13.38389,"median":-9.506697,"eighty":-8.433029,"marketCap":625631134}],"updateTime":1753534567795}}}